Table 1 . summary Distribution of all variables ,Groupwise
Table 1 . Summary Distribution of all variables
| label | levels | all |
|---|---|---|
| Age | Mean (SD) | 53.9 (9.4) |
| Magnesium | Mean (SD) | 2.0 (0.5) |
| FEV1 | Mean (SD) | 49.9 (10.1) |
| Exacerbations | 0 | 2 (2.2) |
| 1 | 19 (21.1) | |
| 2 | 21 (23.3) | |
| 3 | 31 (34.4) | |
| 4 | 14 (15.6) | |
| 5 | 3 (3.3) | |
| FVC | Mean (SD) | 60.8 (9.9) |
| BMI | Mean (SD) | 23.6 (2.2) |
| Protein | Mean (SD) | 7.1 (2.1) |
| Group | AECOPD<=2 | 42 (46.7) |
| AECOPD>=3 | 48 (53.3) | |
| Sex | Female | 12 (13.3) |
| Male | 78 (86.7) | |
| Smoker | Ex-Smoker | 65 (72.2) |
| Non-smoker | 7 (7.8) | |
| Smoker | 18 (20.0) | |
| comorbidities | CAD | 16 (17.8) |
| Hypertension | 27 (30.0) | |
| Other | 16 (17.8) | |
| Type 2 DM | 31 (34.4) | |
| Platelets | Mean (SD) | 2.9 (0.6) |
| Uric_Acid | Mean (SD) | 7.1 (2.1) |
| Urea | Mean (SD) | 29.8 (14.5) |
| Creatinine | Mean (SD) | 1.1 (0.1) |
| Albumin | Mean (SD) | 3.7 (0.5) |
| Glucose | Mean (SD) | 129.6 (29.7) |
| Anthonisen_Type | Type 1 | 60 (66.7) |
| Type 2 | 19 (21.1) | |
| Type 3 | 11 (12.2) | |
| COPD_Stage | Moderate | 44 (48.9) |
| Severe | 44 (48.9) | |
| Very Severe | 2 (2.2) |
Table 2 . Summary Distribution of all variables ,Groupwise
| Dependent: Group | AECOPD<=2 | AECOPD>=3 | p | |
|---|---|---|---|---|
| Age | Mean (SD) | 57.0 (9.5) | 51.3 (8.5) | 0.003 |
| Magnesium | Mean (SD) | 2.2 (0.4) | 1.7 (0.4) | <0.001 |
| FEV1 | Mean (SD) | 55.3 (7.7) | 45.1 (9.5) | <0.001 |
| Exacerbations | Mean (SD) | 1.5 (0.6) | 3.4 (0.6) | <0.001 |
| FVC | Mean (SD) | 64.2 (9.9) | 57.8 (9.0) | 0.003 |
| BMI | Mean (SD) | 24.2 (2.1) | 23.1 (2.1) | 0.012 |
| Protein | Mean (SD) | 7.7 (2.2) | 6.5 (1.9) | 0.009 |
| Sex | Female | 7 (16.7) | 5 (10.4) | 0.384 |
| Male | 35 (83.3) | 43 (89.6) | ||
| Smoker | Ex-Smoker | 30 (71.4) | 35 (72.9) | 0.839 |
| Non-smoker | 4 (9.5) | 3 (6.2) | ||
| Smoker | 8 (19.0) | 10 (20.8) | ||
| comorbidities | CAD | 8 (19.0) | 8 (16.7) | 0.465 |
| Hypertension | 15 (35.7) | 12 (25.0) | ||
| Other | 8 (19.0) | 8 (16.7) | ||
| Type 2 DM | 11 (26.2) | 20 (41.7) | ||
| Platelets | Mean (SD) | 2.8 (0.6) | 3.0 (0.6) | 0.281 |
| Uric_Acid | Mean (SD) | 6.5 (1.9) | 7.6 (2.2) | 0.015 |
| Urea | Mean (SD) | 28.9 (13.6) | 30.6 (15.3) | 0.381 |
| Creatinine | Mean (SD) | 1.1 (0.1) | 1.1 (0.1) | 0.465 |
| Albumin | Mean (SD) | 3.7 (0.6) | 3.8 (0.4) | 0.403 |
| Glucose | Mean (SD) | 134.8 (26.6) | 125.1 (31.8) | 0.142 |
| Anthonisen_Type | Type 1 | 34 (81.0) | 26 (54.2) | 0.009 |
| Type 2 | 7 (16.7) | 12 (25.0) | ||
| Type 3 | 1 (2.4) | 10 (20.8) | ||
| COPD_Stage | Moderate | 31 (73.8) | 13 (27.1) | <0.001 |
| Severe | 11 (26.2) | 33 (68.8) | ||
| Very Severe | 0 (0.0) | 2 (4.2) |
Distribution of Demographic Variables in Our Population
Fig.1 Plot of Age distribution across Groups
The Dodged bar chart above represents individual counts representing frequency of age_grp categories 50-60,40-50,60-70,30-40,70-80 and 10-20 in categories AECOPD<=2 and AECOPD>=3 belonging to group Group. Subgroup 50-60 has highest percentage 17/42 ( 40.48 % ) in group AECOPD<=2 . Subgroup 50-60 has highest percentage 19/48 ( 39.58 % ) in group AECOPD>=3 . To formally check for association between groups we performed pearson chi-square test .
we found a Significant association between age_grp and Group. The chi-square statistic was 11.23 . The degree of freedom was 5 and P value was 0.05 .Contingency and Proportion table are shown below
Table 3
| Group | age_grp | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| AECOPD<=2 | 40-50 | 6 | 6/42 ( 14.29 %) | 6.19% - 27.1% |
| AECOPD<=2 | 50-60 | 17 | 17/42 ( 40.48 %) | 26.67% - 55.54% |
| AECOPD<=2 | 60-70 | 11 | 11/42 ( 26.19 %) | 14.78% - 40.75% |
| AECOPD<=2 | 70-80 | 4 | 4/42 ( 9.52 %) | 3.3% - 21.07% |
| AECOPD>=3 | 40-50 | 13 | 13/48 ( 27.08 %) | 16.11% - 40.72% |
| AECOPD>=3 | 50-60 | 19 | 19/48 ( 39.58 %) | 26.69% - 53.69% |
| AECOPD>=3 | 60-70 | 7 | 7/48 ( 14.58 %) | 6.77% - 26.51% |
Table 4
| AECOPD<=2 | AECOPD>=3 | |
|---|---|---|
| 40-50 | 6 | 13 |
| 50-60 | 17 | 19 |
| 60-70 | 11 | 7 |
| 70-80 | 4 | 0 |
Figure 2 Sex Distribution in Our Population
The Dodged bar chart above represents individual counts representing frequency of Sex categories Male and Female in categories AECOPD<=2 and AECOPD>=3 belonging to group Group. Subgroup Male has highest percentage 35/42 ( 83.33 % ) in group AECOPD<=2 . Subgroup Male has highest percentage 43/48 ( 89.58 % ) in group AECOPD>=3 . To formally check for association between groups we performed pearson chi-square test .
we found a Non-significant association between Sex and Group. The chi-square statistic was 0.31 . The degree of freedom was 1 and P value was 0.58 .Contingency and Proportion table are shown below
Table 5
| Group | Sex | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| AECOPD<=2 | Female | 7 | 7/42 ( 16.67 %) | 7.78% - 29.96% |
| AECOPD<=2 | Male | 35 | 35/42 ( 83.33 %) | 70.04% - 92.22% |
| AECOPD>=3 | Female | 5 | 5/48 ( 10.42 %) | 4.09% - 21.33% |
| AECOPD>=3 | Male | 43 | 43/48 ( 89.58 %) | 78.67% - 95.91% |
Table 6
| AECOPD<=2 | AECOPD>=3 | |
|---|---|---|
| Female | 7 | 5 |
| Male | 35 | 43 |
Figure 3 Distribution Of smokers in Our Population
The Dodged bar chart above represents individual counts representing frequency of Smoker categories Ex-Smoker,Smoker and Non-smoker in categories AECOPD<=2 and AECOPD>=3 belonging to group Group. Subgroup Ex-Smoker has highest percentage 30/42 ( 71.43 % ) in group AECOPD<=2 . Subgroup Ex-Smoker has highest percentage 35/48 ( 72.92 % ) in group AECOPD>=3 . To formally check for association between groups we performed pearson chi-square test .
we found a Non-significant association between Smoker and Group. The chi-square statistic was 0.35 . The degree of freedom was 2 and P value was 0.84 .Contingency and Proportion table are shown below
Table 7
| Group | Smoker | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| AECOPD<=2 | Ex-Smoker | 30 | 30/42 ( 71.43 %) | 56.68% - 83.33% |
| AECOPD<=2 | Non-smoker | 4 | 4/42 ( 9.52 %) | 3.3% - 21.07% |
| AECOPD<=2 | Smoker | 8 | 8/42 ( 19.05 %) | 9.44% - 32.75% |
| AECOPD>=3 | Ex-Smoker | 35 | 35/48 ( 72.92 %) | 59.28% - 83.89% |
| AECOPD>=3 | Non-smoker | 3 | 3/48 ( 6.25 %) | 1.79% - 15.75% |
| AECOPD>=3 | Smoker | 10 | 10/48 ( 20.83 %) | 11.25% - 33.82% |
Table 8
| AECOPD<=2 | AECOPD>=3 | |
|---|---|---|
| Ex-Smoker | 30 | 35 |
| Non-smoker | 4 | 3 |
| Smoker | 8 | 10 |
Figure 4 Distribution Of Anthonisen Classification in Our Population
The Dodged bar chart above represents individual counts representing frequency of Anthonisen_Type categories Type 1,Type 3 and Type 2 in categories AECOPD<=2 and AECOPD>=3 belonging to group Group. Subgroup Type 1 has highest percentage 34/42 ( 80.95 % ) in group AECOPD<=2 . Subgroup Type 1 has highest percentage 26/48 ( 54.17 % ) in group AECOPD>=3 . To formally check for association between groups we performed pearson chi-square test .
we found a Non-significant association between Smoker and Group. The chi-square statistic was 0.35 . The degree of freedom was 2 and P value was 0.84 .Contingency and Proportion table are shown below
Table 9
| Group | Anthonisen_Type | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| AECOPD<=2 | Type 1 | 34 | 34/42 ( 80.95 %) | 67.25% - 90.56% |
| AECOPD<=2 | Type 2 | 7 | 7/42 ( 16.67 %) | 7.78% - 29.96% |
| AECOPD<=2 | Type 3 | 1 | 1/42 ( 2.38 %) | 0.26% - 10.59% |
| AECOPD>=3 | Type 1 | 26 | 26/48 ( 54.17 %) | 40.17% - 67.67% |
| AECOPD>=3 | Type 2 | 12 | 12/48 ( 25 %) | 14.45% - 38.46% |
| AECOPD>=3 | Type 3 | 10 | 10/48 ( 20.83 %) | 11.25% - 33.82% |
Table 10
| AECOPD<=2 | AECOPD>=3 | |
|---|---|---|
| Ex-Smoker | 30 | 35 |
| Non-smoker | 4 | 3 |
| Smoker | 8 | 10 |
Figure 5 Distribution Of COPD Stage according to GOLD Criteria in Our Population
The Dodged bar chart above represents individual counts representing frequency of COPD_Stage categories Moderate,Severe and Very Severe in categories AECOPD<=2 and AECOPD>=3 belonging to group Group. Subgroup Moderate has highest percentage 31/42 ( 73.81 % ) in group AECOPD<=2 . Subgroup Severe has highest percentage 33/48 ( 68.75 % ) in group AECOPD>=3 . To formally check for association between groups we performed pearson chi-square test .
twe found a Significant association between COPD_Stage and Group. The chi-square statistic was 20.05 . The degree of freedom was 2 and P value was <0.001 .Contingency and Proportion table are shown below
Table 11
| Group | COPD_Stage | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| AECOPD<=2 | Moderate | 31 | 31/42 ( 73.81 %) | 59.25% - 85.22% |
| AECOPD<=2 | Severe | 11 | 11/42 ( 26.19 %) | 14.78% - 40.75% |
| AECOPD>=3 | Moderate | 13 | 13/48 ( 27.08 %) | 16.11% - 40.72% |
| AECOPD>=3 | Severe | 33 | 33/48 ( 68.75 %) | 54.84% - 80.48% |
| AECOPD>=3 | Very Severe | 2 | 2/48 ( 4.17 %) | 0.88% - 12.7% |
Table 12
| AECOPD<=2 | AECOPD>=3 | |
|---|---|---|
| Moderate | 31 | 13 |
| Severe | 11 | 33 |
| Very Severe | 0 | 2 |
Figure 6 Boxplot Of Distribution Of LDL in our Population
In this Figure we see Box plot of Magnesium in 2 sub-groups of Group : AECOPD<=2 and AECOPD>=3 respectively .The individual jittered data points of Magnesium are overlaid over transparent Boxplot for better visualisation. We see distribution of data in individual sub-groups of Group based on these box-plots. The lower edge of box plot represents -first quartile (Q1), Horizontal bar represents the median, Upper edge represnts third quartile (Q3), Two black lines (whiskers) emanating from box-plots signify range of non-outlier data for the particular sub-group. Lower whisker represents minimum(Q1- 1.5 interquartile range) non-outlier limit of Magnesium and upper whisker represnts maximum(Q1+1.5interquartile range) of Magnesium .Any data beyond whiskers of box-plots represents outliers in the sub-groups The big brown point in the box-plots represents mean Magnesium of 2 groups and it has been annotated in the figure itself
Table 13 Summary Table Of Magnesium within Groups
| Group | n | Mean | SD | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|
| AECOPD<=2 | 42 | 2.238 | 0.406 | 2.201 | 1.417 | 3.09 |
| AECOPD>=3 | 48 | 1.726 | 0.437 | 1.786 | 0.635 | 2.53 |
We formally performed a Welch’s independent Sample T test between Two Groups. The mean in Group AECOPD<=2 [ 2.24 ± 0.41 ] was significantly higher than Group AECOPD>=3 [ 1.73 ± 0.44 ] . The mean difference was 0.51 and 95 % confidence interval of the difference was ( 0.33 - 0.69 ) . The p value was <0.001 . The t statistic was 5.76 and degree of freedom of the Welch unpaired two-sample t test was 87.69 .In Formal statistical notation this result is expressed as : t(87.69) = 5.76, p= <0.001.
Table 14 Results Of T test
| AECOPD<=2 | AECOPD>=3 | Degree of Freedom | T statistic | Difference | 95 % C.I. | P value |
|---|---|---|---|---|---|---|
| 2.24 ± 0.41 | 1.73 ± 0.44 | 87.69 | 5.76 | 0.51 | 0.33 - 0.69 | <0.001 |
Figure 7 Boxplot Of Age-Sex Distribution Of Magnesium in our Population
Table 15 Age-Sex Distribution Of Magnesium in our Population
| Group | age_grp | Sex | n | Mean ( Magnesium ) | SD ( Magnesium ) | Median ( Magnesium ) |
|---|---|---|---|---|---|---|
| AECOPD<=2 | 40-50 | Female | 2 | 2.89 | 0.11 | 2.89 |
| AECOPD<=2 | 40-50 | Male | 4 | 1.97 | 0.64 | 1.87 |
| AECOPD<=2 | 50-60 | Female | 4 | 2.51 | 0.46 | 2.69 |
| AECOPD<=2 | 50-60 | Male | 13 | 2.19 | 0.3 | 2.13 |
| AECOPD<=2 | 60-70 | Female | 1 | 2.06 | 2.06 | |
| AECOPD<=2 | 60-70 | Male | 10 | 2.21 | 0.22 | 2.22 |
| AECOPD<=2 | 70-80 | Male | 4 | 2.39 | 0.58 | 2.30 |
| AECOPD>=3 | 40-50 | Female | 1 | 1.47 | 1.47 | |
| AECOPD>=3 | 40-50 | Male | 12 | 1.76 | 0.36 | 1.82 |
| AECOPD>=3 | 50-60 | Female | 2 | 1.10 | 0.52 | 1.10 |
| AECOPD>=3 | 50-60 | Male | 17 | 1.74 | 0.45 | 1.80 |
| AECOPD>=3 | 60-70 | Male | 7 | 1.59 | 0.46 | 1.79 |
Figure showing Correlation between Number Of Exacebations and Magnesium
The scatter plots above show relationship between Magnesium on X axis and Exacerbations on Y axis. Graphically, we see that as Magnesium increases, Exacerbations decreases . On a formal statistical linear regression analysis, we that line of best fit (blue line signifying line with least square difference) also has a negative slope implying a negative correlation. The gray shaded error around blue line signifies 95% confidence interval of linear regression line of best fit. The correlation between two variables is Significant . The Pearson’s correlation between Magnesium and Exacerbations is -0.55 with 95% Confidence Interval of -0.68 to -0.38. the t statistic is -6.13 The p value is <0.001 .The degree of freedom is 88. In formal statistical notation this expressed as t(88)= -6.13, P= <0.001. r(Pearson) = -0.55 95% C.I. [-0.68–0.38]. n= 90. The correlation is summmarised in table below
Table 16. Table Summarizing correlation between Magnesium and Number Of Exacerbations
| Group 1 | Group 2 | Degree of Freedom | T statistic | Correlation | 95 % C.I. | P value |
|---|---|---|---|---|---|---|
| Magnesium | Exacerbations | 88 | -6.13 | -0.55 | -0.68–0.38 | <0.001 |
Table 17 Table with summary statistics of Magnesium and Number Of Exacerbations
| variable | n | Mean | SD | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|
| Exacerbations | 90 | 2.500 | 1.154 | 3.000 | 0.000 | 5.00 |
| Magnesium | 90 | 1.965 | 0.493 | 1.973 | 0.635 | 3.09 |
Figure showing Correlation between FEV1 and Magnesium
The scatter plots above show relationship between Magnesium on X axis and FEV1 on Y axis. Graphically, we see that as Magnesium increases, FEV1 also increases . On a formal statistical linear regression analysis, we that line of best fit (blue line signifying line with least square difference) also has a positive slope implying a positive correlation. The gray shaded error around blue line signifies 95% confidence interval of linear regression line of best fit. The correlation between two variables is Significant . The Pearson’s correlation between Magnesium and FEV1 is 0.24 with 95% Confidence Interval of 0.03 to 0.43. the t statistic is 2.31 The p value is 0.02 .The degree of freedom is 88. In formal statistical notation this expressed as t(88)= 2.31, P= 0.02. r(Pearson) = 0.24 95% C.I. [0.03-0.43]. n= 90. The correlation is summmarised in table below
Table 18. Table Summarizing correlation between Magnesium and FEV1
| Group 1 | Group 2 | Degree of Freedom | T statistic | Correlation | 95 % C.I. | P value |
|---|---|---|---|---|---|---|
| Magnesium | FEV1 | 88 | 2.31 | 0.24 | 0.03-0.43 | 0.02 |
Table 19 Table with summary statistics of Magnesium and FEV1
| variable | n | Mean | SD | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|
| Exacerbations | 90 | 2.500 | 1.154 | 3.000 | 0.000 | 5.00 |
| Magnesium | 90 | 1.965 | 0.493 | 1.973 | 0.635 | 3.09 |
Table 20 Correlation table of Selected variables Magnesium,Exacerbations,BMI,FEV1,FVC,Age,Protei with their confidence intervals
| Variable1 | Variable2 | Correlation | pvalue | significance | Confidence_Interval |
|---|---|---|---|---|---|
| Exacerbations | FEV1 | -0.58 | <0.001 | Significant | -0.7–0.43 |
| Magnesium | Exacerbations | -0.55 | <0.001 | Significant | -0.68–0.38 |
| Exacerbations | Age | -0.39 | <0.001 | Significant | -0.55–0.2 |
| Exacerbations | FVC | -0.37 | <0.001 | Significant | -0.53–0.17 |
| Exacerbations | BMI | -0.35 | <0.001 | Significant | -0.52–0.15 |
| FEV1 | Protein | 0.31 | 0.00282 | Significant | 0.11-0.49 |
| FVC | Age | -0.26 | 0.014 | Significant | -0.44–0.05 |
| Exacerbations | Protein | -0.25 | 0.0173 | Significant | -0.43–0.05 |
| Magnesium | FVC | 0.24 | 0.0203 | Significant | 0.04-0.43 |
| Magnesium | FEV1 | 0.24 | 0.0232 | Significant | 0.03-0.43 |
| BMI | FEV1 | 0.23 | 0.031 | Significant | 0.02-0.42 |
| BMI | Age | 0.22 | 0.0372 | Significant | 0.01-0.41 |
| BMI | Protein | 0.21 | 0.0507 | Non-Significant | 0-0.4 |
| FEV1 | Age | -0.19 | 0.0748 | Non-Significant | -0.38-0.02 |
| BMI | FVC | -0.18 | 0.0817 | Non-Significant | -0.38-0.02 |
| Magnesium | Age | 0.09 | 0.377 | Non-Significant | -0.12-0.3 |
| Magnesium | BMI | 0.06 | 0.571 | Non-Significant | -0.15-0.26 |
| FVC | Protein | 0.06 | 0.575 | Non-Significant | -0.15-0.26 |
| Magnesium | Protein | 0.06 | 0.585 | Non-Significant | -0.15-0.26 |
| Age | Protein | -0.05 | 0.643 | Non-Significant | -0.25-0.16 |
| FEV1 | FVC | 0.00 | 0.987 | Non-Significant | -0.21-0.21 |
Multiple linear regression was conducted to find best combination of Magnesium,FEV1,BMI,FVC & Age for predicting Exacerbations . Dummy indicator(0/1) were used for categorical variables. The Forest plot above shows standardized regression coefficients of Magnesium,FEV1,BMI,FVC & Age with their confidence intervals as horizontal error bars on X axis. An error bar which crosses vertical line of zero in this plot is non-significant.
The combination of these predictors significantly predicted Exacerbations .There were 90 observations in our model. The number of predictors in model was 5 ,while degree of freedom of residuals(no.of observation-number Of predictors in model) was 84. In statistical notation this is expressed as F(5,84) = 218.16, P = <0.001 .The standard deviation of residual error was 0.32 implying Exacerbations was predicted with average accuracy of +- 0.32 by our model. The adjusted R - Square for our model is 0.92 implying our model predicts 92.42 percentage variation in Exacerbations .
In Our Multivariable linear regression Model,On adjusting for all variables , Magnesium,FEV1,BMI,FVC & Age significantly predicted Exacerbations .
Out of all variables, FEV1 [ Beta = -0.7 +- 0.1 ] had highest standardized regression coefficient and contributed maximum to predicted Exacerbations .
Our Final regression equation was predicted Exacerbations = 15.66+-0.46Magnesium +-0.07FEV1 +-0.07BMI +-0.06FVC +-0.06*Age
Interpretation
1 unit change in Magnesium leads to 0.46 decrease in Exacerbations . 1 unit change in FEV1 leads to 0.07 decrease in Exacerbations . 1 unit change in BMI leads to 0.07 decrease in Exacerbations . 1 unit change in FVC leads to 0.06 decrease in Exacerbations . 1 unit change in Age leads to 0.06 decrease in Exacerbations
Table 21 Univariable and Multivariable Regression coefficients
| Dependent: Exacerbations | Mean (sd) | Coefficient (univariable) | Coefficient (multivariable) | |
|---|---|---|---|---|
| Age | [40,78] | 2.5 (1.2) | -0.05 (-0.07 to -0.02, p<0.001) | -0.07 (-0.08 to -0.06, p<0.001) |
| BMI | [18,29.1] | 2.5 (1.2) | -0.19 (-0.29 to -0.08, p=0.001) | -0.09 (-0.12 to -0.06, p<0.001) |
| FEV1 | [26.9,69] | 2.5 (1.2) | -0.07 (-0.09 to -0.05, p<0.001) | -0.07 (-0.08 to -0.06, p<0.001) |
| FVC | [27.8,81.1] | 2.5 (1.2) | -0.04 (-0.07 to -0.02, p<0.001) | -0.06 (-0.06 to -0.05, p<0.001) |
| Magnesium | [0.635,3.09] | 2.5 (1.2) | -1.28 (-1.70 to -0.87, p<0.001) | -0.52 (-0.66 to -0.37, p<0.001) |
In the ROC and Distribution Curve Magnesium concentration above above predictor above cut off 1.94 had maximum Youden’s index(sum of sensitivity and specificity) to discriminate AECOPD<=2 from AECOPD>=3. A value above 1.94 had sensitivity of 78.57 % and specificity of 70.83 % with area under curve of 0.80 to predict AECOPD<=2. The accuracy of prediction was 74.44 %
| category | thresholds | sensitivities | specificities | PLR | NLR | prevalence | PPV | NPV | youden |
|---|---|---|---|---|---|---|---|---|---|
| max_sensitivity | 2.53 | 0.98 | 0.21 | 1.25 | 0.10 | 0.4 | 0.45 | 0.63 | 0.19 |
| max_specificity | 1.47 | 0.27 | 0.98 | 11.37 | 0.75 | 0.4 | 0.88 | 0.45 | 0.25 |
| youden | 1.94 | 0.71 | 0.79 | 3.31 | 0.37 | 0.4 | 0.69 | 0.53 | 0.49 |
| max_PPV | 1.47 | 0.27 | 0.98 | 11.37 | 0.75 | 0.4 | 0.88 | 0.45 | 0.25 |
| max_NPV | 2.42 | 0.98 | 0.36 | 1.52 | 0.06 | 0.4 | 0.50 | 0.64 | 0.34 |
| max_PLR | 1.47 | 0.27 | 0.98 | 11.37 | 0.75 | 0.4 | 0.88 | 0.45 | 0.25 |
| min_NLR | 2.42 | 0.98 | 0.36 | 1.52 | 0.06 | 0.4 | 0.50 | 0.64 | 0.34 |